Search research articles
Contact Us
Filters
Showing results (891-900 of 949) with videos related to
Page
of 95
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid, Susan E Dorman, Narges Alipanah, et al.
Annals of Neurology
|
February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
J H Simon, L D Jacobs, M Campion, et al.
Neurology
|
August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
R A Rudick, D E Goodkin, L D Jacobs, et al.
Annals of Neurology
|
March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
L D Jacobs, D L Cookfair, R A Rudick, et al.
The Lancet. Infectious Diseases
|
May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Sharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Physical Review Letters
|
March 23, 2002
Evidence for a new low-lying resonance state in 7He
M Meister, K Markenroth, D Aleksandrov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 13, 1999
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG)
D E Goodkin, R L Priore, K E Wende, et al.
Journal of Neuroimmunology
|
June 23, 1999
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
R A Rudick, D L Cookfair, N A Simonian, et al.
Physical Review Letters
|
June 6, 2020
Evidence for a New Compact Symmetric Fission Mode in Light Thorium Isotopes
A Chatillon, J Taïeb, H Alvarez-Pol, et al.
Physical Review Letters
|
August 25, 2004
Shell structure of the near-dripline nucleus 23O
D Cortina-Gil, J Fernandez-Vazquez, T Aumann, et al.
Page
of 95
Search research articles
Search
Showing results (891-900 of 949) with videos related to
Sort By:
Page
of 95
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid, Susan E Dorman, Narges Alipanah, et al.
Annals of Neurology
|
February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
J H Simon, L D Jacobs, M Campion, et al.
Neurology
|
August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
R A Rudick, D E Goodkin, L D Jacobs, et al.
Annals of Neurology
|
March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
L D Jacobs, D L Cookfair, R A Rudick, et al.
The Lancet. Infectious Diseases
|
May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Sharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Physical Review Letters
|
March 23, 2002
Evidence for a new low-lying resonance state in 7He
M Meister, K Markenroth, D Aleksandrov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 13, 1999
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG)
D E Goodkin, R L Priore, K E Wende, et al.
Journal of Neuroimmunology
|
June 23, 1999
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
R A Rudick, D L Cookfair, N A Simonian, et al.
Physical Review Letters
|
June 6, 2020
Evidence for a New Compact Symmetric Fission Mode in Light Thorium Isotopes
A Chatillon, J Taïeb, H Alvarez-Pol, et al.
Physical Review Letters
|
August 25, 2004
Shell structure of the near-dripline nucleus 23O
D Cortina-Gil, J Fernandez-Vazquez, T Aumann, et al.
Page
of 95